Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This study delves into how different versions of the HNF4A gene affect inflammatory bowel disease development.

The HNF4A gene produces a key regulatory protein that controls gene expression and is connected to multiple health outcomes with inflammatory bowel disease (IBD) being a prominent condition. Join me as we examine complex genetic mechanisms and investigate how different forms of the HNF4A gene can affect your well-being.

The HNF4A gene produces a transcription factor protein which controls liver gene activity.

The protein serves multiple functions including vital organ formation of the liver, kidneys, and intestines along with activating detoxifying enzymes and producing sex hormone-regulating proteins while also managing insulin resistance. Scientific studies show that genetic changes in the HNF4A gene may increase the odds of developing diabetes, metabolic syndrome and especially inflammatory bowel disease (IBD).

Research demonstrates a significant correlation between certain HNF4A gene variants and increased risk for ulcerative colitis as a subtype of inflammatory bowel disease.

A genome-wide analysis of over 7,000 European-descent individuals revealed significant connections between UC rates and the 'C' allele presence at rs6017342. Analysis of Dutch and Korean patient samples numbering 2,000 and 1,900 respectively showed carriers of the 'C' allele faced substantially increased risks for UC.

The essential function of HNF4A protein in preserving intestinal mucosal barriers highlights its important role in IBD pathophysiology.

The protective barrier safeguards the intestinal lining and enables nutrients to get absorbed. The reduction of HNF4A protein levels through genetic variations weakens the intestinal mucosal barrier which accelerates the development of IBD.

The knowledge of genetic factors in health conditions helps people select better health management options.

Those who believe they might have a genetic tendency toward IBD or similar conditions should look into Precision Health & Wellness tests provided by PlexusDx. Understanding your genetic makeup enables you to actively manage your well-being while creating tailored health solutions with medical professionals.

The complex relationship between HNF4A gene variants and their impact on inflammatory bowel disease risk emphasizes the importance of personalized medical knowledge.

You can now unlock the secrets of your genetic makeup by taking PlexusDx Precision Health & Wellness tests available through PlexusDx.com, Amazon, and Walmart. Take control of your health path to start a journey built around your genetic profile.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves